187-1(Cat No.:P000142)is a small-molecule inhibitor that targets neural Wiskott–Aldrich Syndrome Protein (N-WASP), a key regulator of actin cytoskeleton remodeling through activation of the Arp2/3 complex. By inhibiting N-WASP, 187-1 disrupts actin polymerization, thereby affecting cell motility, endocytosis, and intracellular trafficking. This inhibitor is widely used in research to probe cytoskeletal dynamics, pathogen-host interactions, and cancer cell invasion. Its specificity makes it a valuable tool for dissecting actin-dependent signaling pathways and exploring therapeutic strategies in oncology, infectious disease, and disorders linked to abnormal cytoskeletal regulation.